Raludotatug Deruxtecan (R-DXd)

Raludotatug deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Raludotatug Deruxtecan (R-DXd), covering 2026-01-12 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005) [Phase 2]